Emmarie Huetteman and Jay Hancock, Kaiser Health News

Nation

Congress to square off against pharmaceutical CEOs in showdown over drug prices

Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.